Interplay between liver type 1 innate lymphoid cells and NK cells drives the development of alcoholic steatohepatitis
From these metrics, participants were stratified into four clinical groups: neuropathological AD diagnosis with dementia (dementia, 25 participants), neuropathological AD diagnosis without dementia (resilient, 25 participants), no AD or other neurological disease diagnosis with dementia (frail, 26 participants), and a control group with no AD or other neurological disease diagnosis and negligible cognitive decline at time of death (control, 26 participants)
Oral supplements and dietary improvements are safer, more affordable, and sufficient for most people
Clinical trials showed 22.5% average weight loss at this level over 72 weeks
Eli Lilly, which makes Mounjaro and Zepbound, is also working on a daily GLP-1 pill, called orforglipron
For many users, this convenience outweighs potential advantages of alternative treatments